Krsnaa Diagnostics' board approved Q1 financial results.

Consolidated revenue reached ₹192.98 Cr, with profit after tax at ₹20.52 Cr.

The company's 15th AGM will be held on September 25, where shareholders will vote on a final dividend of ₹2.75 per share for FY24-25. A key item for shareholder approval is the continuation of Mr. Chetan Desai's director appointment.

Separately, the company is contesting an income tax demand of ₹51.39 Cr, having paid ₹10.28 Cr under protest.

Management remains confident this will not materially impact financials.